BR9509897A - Composição de liberação controlada para um material biologicamente ativo uso da mesma processo para preparação de uma composição de liberação controlada e para administração a mamíferos especialmente ao homem de um material biologicamante ativo e composição para uso como uma composição medicinal nasal - Google Patents
Composição de liberação controlada para um material biologicamente ativo uso da mesma processo para preparação de uma composição de liberação controlada e para administração a mamíferos especialmente ao homem de um material biologicamante ativo e composição para uso como uma composição medicinal nasalInfo
- Publication number
- BR9509897A BR9509897A BR9509897A BR9509897A BR9509897A BR 9509897 A BR9509897 A BR 9509897A BR 9509897 A BR9509897 A BR 9509897A BR 9509897 A BR9509897 A BR 9509897A BR 9509897 A BR9509897 A BR 9509897A
- Authority
- BR
- Brazil
- Prior art keywords
- composition
- active material
- biologically active
- controlled release
- pct
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2984—Microcapsule with fluid core [includes liposome]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Detergent Compositions (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Surface Acoustic Wave Elements And Circuit Networks Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9404289A SE518619C2 (sv) | 1994-12-09 | 1994-12-09 | Komposition för reglerad frisättning innehållande monokaproin |
PCT/SE1995/001479 WO1996017597A1 (en) | 1994-12-09 | 1995-12-08 | Controlled release composition forming a reversed micellar (l2) structure or a normal micellar (l1) structure |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9509897A true BR9509897A (pt) | 1997-12-30 |
Family
ID=20396276
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9509897A BR9509897A (pt) | 1994-12-09 | 1995-12-08 | Composição de liberação controlada para um material biologicamente ativo uso da mesma processo para preparação de uma composição de liberação controlada e para administração a mamíferos especialmente ao homem de um material biologicamante ativo e composição para uso como uma composição medicinal nasal |
Country Status (13)
Country | Link |
---|---|
US (1) | US5906831A (pt) |
EP (1) | EP0790822B1 (pt) |
JP (1) | JP3487860B2 (pt) |
AT (1) | ATE213932T1 (pt) |
AU (1) | AU4276896A (pt) |
BR (1) | BR9509897A (pt) |
CA (1) | CA2207218C (pt) |
DE (1) | DE69525761T2 (pt) |
ES (1) | ES2170171T3 (pt) |
FI (1) | FI972415A (pt) |
NO (1) | NO972614D0 (pt) |
SE (1) | SE518619C2 (pt) |
WO (1) | WO1996017597A1 (pt) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8765177B2 (en) * | 1997-09-12 | 2014-07-01 | Columbia Laboratories, Inc. | Bioadhesive progressive hydration tablets |
US7153845B2 (en) * | 1998-08-25 | 2006-12-26 | Columbia Laboratories, Inc. | Bioadhesive progressive hydration tablets |
US6761903B2 (en) | 1999-06-30 | 2004-07-13 | Lipocine, Inc. | Clear oil-containing pharmaceutical compositions containing a therapeutic agent |
US6458383B2 (en) | 1999-08-17 | 2002-10-01 | Lipocine, Inc. | Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin |
US20020153508A1 (en) * | 2000-06-29 | 2002-10-24 | Lynch Matthew Lawrence | Cubic liquid crystalline compositions and methods for their preparation |
EP1463545B3 (en) * | 2001-11-08 | 2008-12-10 | Atrium Medical Corporation | Intraluminal device with a coating containing a therapeutic agent |
JP2005515197A (ja) * | 2001-12-03 | 2005-05-26 | ドー バイオファーマ インコーポレイテッド | 安定化された逆ミセル組成物およびその使用 |
GB0210397D0 (en) | 2002-05-07 | 2002-06-12 | Ferring Bv | Pharmaceutical formulations |
US9801982B2 (en) | 2004-09-28 | 2017-10-31 | Atrium Medical Corporation | Implantable barrier device |
US9592324B2 (en) | 2006-11-06 | 2017-03-14 | Atrium Medical Corporation | Tissue separating device with reinforced support for anchoring mechanisms |
US8001922B2 (en) | 2004-09-28 | 2011-08-23 | Atrium Medical Corporation | Application of a coating on a medical device |
US8312836B2 (en) | 2004-09-28 | 2012-11-20 | Atrium Medical Corporation | Method and apparatus for application of a fresh coating on a medical device |
US9012506B2 (en) | 2004-09-28 | 2015-04-21 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
WO2006036970A2 (en) * | 2004-09-28 | 2006-04-06 | Atrium Medical Corporation | Method of thickening a coating using a drug |
US9000040B2 (en) | 2004-09-28 | 2015-04-07 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
US8367099B2 (en) | 2004-09-28 | 2013-02-05 | Atrium Medical Corporation | Perforated fatty acid films |
EP1819297B1 (en) | 2004-09-28 | 2015-01-14 | Atrium Medical Corporation | Uv cured gel and method of making |
US20060127437A1 (en) * | 2004-12-13 | 2006-06-15 | Misty Anderson Kennedy | Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids |
US8535709B2 (en) * | 2004-12-13 | 2013-09-17 | Southeastern Medical Technologies, Llc | Agents for controlling biological fluids and methods of use thereof |
US20070059350A1 (en) * | 2004-12-13 | 2007-03-15 | Kennedy John P | Agents for controlling biological fluids and methods of use thereof |
US9427423B2 (en) | 2009-03-10 | 2016-08-30 | Atrium Medical Corporation | Fatty-acid based particles |
US9278161B2 (en) | 2005-09-28 | 2016-03-08 | Atrium Medical Corporation | Tissue-separating fatty acid adhesion barrier |
EP1933991A4 (en) | 2005-10-15 | 2012-05-02 | Atrium Medical Corp | HYDROPHOBIC NETWORKED GEL FOR BIOABSORBIBLE MEDICINAL CARRIER COVERS |
US7670997B2 (en) * | 2006-06-08 | 2010-03-02 | Bausch & Lomb Incorporated | Ophthalmic compositions comprising a branched, glycerol monoalkyl compound and a fatty acid monoester |
US9492596B2 (en) | 2006-11-06 | 2016-11-15 | Atrium Medical Corporation | Barrier layer with underlying medical device and one or more reinforcing support structures |
WO2009021007A1 (en) | 2007-08-06 | 2009-02-12 | Serenity Pharmaceuticals Corporation | Methods and devices for desmopressin drug delivery |
US20100286045A1 (en) | 2008-05-21 | 2010-11-11 | Bjarke Mirner Klein | Methods comprising desmopressin |
NO2296686T3 (pt) * | 2008-05-21 | 2014-07-12 | ||
US11963995B2 (en) | 2008-05-21 | 2024-04-23 | Ferring B.V. | Methods comprising desmopressin |
US11304960B2 (en) | 2009-01-08 | 2022-04-19 | Chandrashekar Giliyar | Steroidal compositions |
US20110038910A1 (en) | 2009-08-11 | 2011-02-17 | Atrium Medical Corporation | Anti-infective antimicrobial-containing biomaterials |
EP2593141B1 (en) | 2010-07-16 | 2018-07-04 | Atrium Medical Corporation | Composition and methods for altering the rate of hydrolysis of cured oil-based materials |
US9034858B2 (en) | 2010-11-30 | 2015-05-19 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US9358241B2 (en) | 2010-11-30 | 2016-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US20180153904A1 (en) | 2010-11-30 | 2018-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US20120148675A1 (en) | 2010-12-10 | 2012-06-14 | Basawaraj Chickmath | Testosterone undecanoate compositions |
US9867880B2 (en) | 2012-06-13 | 2018-01-16 | Atrium Medical Corporation | Cured oil-hydrogel biomaterial compositions for controlled drug delivery |
US9744542B2 (en) | 2013-07-29 | 2017-08-29 | Apeel Technology, Inc. | Agricultural skin grafting |
US20170246187A1 (en) | 2014-08-28 | 2017-08-31 | Lipocine Inc. | (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE |
WO2016033556A1 (en) | 2014-08-28 | 2016-03-03 | Lipocine Inc. | BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS |
CN107709349B (zh) | 2015-05-20 | 2022-01-28 | 阿比尔技术公司 | 植物提取物组合物和制备其的方法 |
EP3349589B1 (en) | 2015-09-16 | 2022-12-14 | Apeel Technology, Inc. | Method for forming a protective coating by applying fatty acid glyceride compounds to a surface |
WO2017100636A1 (en) | 2015-12-10 | 2017-06-15 | Apeel Technology, Inc. | Plant extract compositions for forming protective coatings |
EP3407713A1 (en) | 2016-01-26 | 2018-12-05 | Apeel Technology, Inc. | Method for preparing and preserving sanitized products |
CN110087475B (zh) | 2016-11-17 | 2023-04-11 | 阿比尔技术公司 | 由植物提取物形成的组合物及其制备方法 |
WO2018098501A1 (en) | 2016-11-28 | 2018-05-31 | Lipocine Inc. | Oral testosterone undecanoate therapy |
US11641865B2 (en) | 2020-03-04 | 2023-05-09 | Apeel Technology, Inc. | Compounds and formulations for protective coatings |
WO2022094339A1 (en) | 2020-10-30 | 2022-05-05 | Apeel Technology, Inc. | Compositions and methods of preparation thereof |
KR20230101840A (ko) * | 2020-11-04 | 2023-07-06 | 인올렉스 인베스트먼트 코포레이션 | 바이오 기반 글리세릴 헵타노에이트 에스테르 조성물, 이를 제조 및 사용하는 방법 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8206744D0 (sv) * | 1982-11-26 | 1982-11-26 | Fluidcarbon International Ab | Preparat for kontrollerad avgivning av substanser |
SE457693B (sv) * | 1986-07-01 | 1989-01-23 | Drilletten Ab | Komposition med reglerad frigoering vari ett biologiskt material aer loest eller dispergerat i en l2-fas |
-
1994
- 1994-12-09 SE SE9404289A patent/SE518619C2/sv not_active IP Right Cessation
-
1995
- 1995-12-08 WO PCT/SE1995/001479 patent/WO1996017597A1/en active IP Right Grant
- 1995-12-08 DE DE69525761T patent/DE69525761T2/de not_active Expired - Fee Related
- 1995-12-08 ES ES95941306T patent/ES2170171T3/es not_active Expired - Lifetime
- 1995-12-08 AU AU42768/96A patent/AU4276896A/en not_active Abandoned
- 1995-12-08 US US08/836,103 patent/US5906831A/en not_active Expired - Fee Related
- 1995-12-08 AT AT95941306T patent/ATE213932T1/de not_active IP Right Cessation
- 1995-12-08 EP EP95941306A patent/EP0790822B1/en not_active Expired - Lifetime
- 1995-12-08 CA CA002207218A patent/CA2207218C/en not_active Expired - Fee Related
- 1995-12-08 BR BR9509897A patent/BR9509897A/pt not_active Application Discontinuation
- 1995-12-08 JP JP51754296A patent/JP3487860B2/ja not_active Expired - Fee Related
-
1997
- 1997-06-06 NO NO972614A patent/NO972614D0/no not_active Application Discontinuation
- 1997-06-06 FI FI972415A patent/FI972415A/fi unknown
Also Published As
Publication number | Publication date |
---|---|
US5906831A (en) | 1999-05-25 |
JP3487860B2 (ja) | 2004-01-19 |
FI972415A0 (fi) | 1997-06-06 |
NO972614L (no) | 1997-06-06 |
ATE213932T1 (de) | 2002-03-15 |
DE69525761T2 (de) | 2002-10-24 |
SE9404289L (sv) | 1996-06-10 |
SE9404289D0 (sv) | 1994-12-09 |
DE69525761D1 (de) | 2002-04-11 |
CA2207218C (en) | 2002-02-12 |
EP0790822A1 (en) | 1997-08-27 |
NO972614D0 (no) | 1997-06-06 |
FI972415A (fi) | 1997-06-06 |
SE518619C2 (sv) | 2002-10-29 |
CA2207218A1 (en) | 1996-06-13 |
EP0790822B1 (en) | 2002-03-06 |
JPH10510260A (ja) | 1998-10-06 |
ES2170171T3 (es) | 2002-08-01 |
WO1996017597A1 (en) | 1996-06-13 |
AU4276896A (en) | 1996-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9509897A (pt) | Composição de liberação controlada para um material biologicamente ativo uso da mesma processo para preparação de uma composição de liberação controlada e para administração a mamíferos especialmente ao homem de um material biologicamante ativo e composição para uso como uma composição medicinal nasal | |
DE69004095T2 (de) | Ein metabolisierbares öl enthaltende impfstoffe und wirkstoffträger. | |
FI942791A (fi) | Sekundaariset amiinit sokeritautia ja liikalihavuutta ehkäisevinä aineina | |
BR9714268A (pt) | Composição de barra para limpeza de pele. | |
ES2101330T3 (es) | Composicion farmaceutica para uso topico que contiene un polimero cationico reticulado y un eter alcoxilado. | |
GB9116610D0 (en) | Preparation of microparticles | |
AR007827A1 (es) | 3-ureido-piridofuranos y -piridotiofenos, procedimiento para su preparacion, composicion que los comprende y uso de dichos compuestos para lapreparacion de medicamentos. | |
BRPI9609033B8 (pt) | composição e emulsão para a liberação controlada de uma substância. | |
PT81857B (pt) | Processo para a preparacao de ingredientes activos a base de 3-(2,2-di-clorovinil)-2,2-dimetil-ciclopropano-carboxilatos de alfa-ciano-3-fenoxibenzilo e de composicoes insecticidas que os contem | |
KR920702217A (ko) | 말라리아 치료 조성물 | |
MXPA97007996A (es) | Preparado para el transporte de sustancias activas a traves de barreras. | |
BR9910329A (pt) | Composto, composição farmacêutica, processo para estimular a liberação do hormÈnio de crescimento da pituitária de um mamìfero, e, uso de um composto | |
ATE253820T1 (de) | Wirkstoffhaltige komposition sowie deren herstellung und verwendung | |
BRPI0015939B8 (pt) | sistema terapêutico transdérmico com estabilidade aperfeiçoada e processo para a sua preparação | |
DK0474712T3 (da) | Anvendelse af lysolecitinderivater til fremstilling af et farmaceutisk præparat | |
BR0116179A (pt) | Composição despejável, processo de preparação de uma composição despejável e uso da composição | |
BR9612355A (pt) | Agentes de ligação com os receptores de ácido hialurÈnico e o uso destes. | |
KR920009406A (ko) | 화상 치료제 | |
KR920019349A (ko) | 불안을 치료하기 위한 r(+)-3-아미노-1-하이드록시-피롤리딘-2-온의 용도 | |
NO894083L (no) | Farmasoeytiske blandinger for behandling av adrenoleukodystrophy. | |
ES2130164T3 (es) | Composicion farmaceutica para aplicacion topica que contiene ditranol y procedimiento de preparacion. | |
KR970061084A (ko) | 닭의 발육을 촉진하는 방법 | |
AR013381A1 (es) | Una composicion liquida acuosa de limpieza y antibacteriana y el procedimiento para prepararla | |
KR880000094A (ko) | 위염치료제 | |
ATE19472T1 (de) | Verwendung von 5-phenyl-1,4-benzodoazepinen zur herstellung von analgetisch wirksamen pharmazeutischen zubereitungen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA10 | Dismissal: dismissal - article 33 of industrial property law |